Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Business Wire
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provided its financial guidance for the year ending December 31, 2026.Fourth Quarter 2025 Financial and Strategic HighlightsAchieved record quarterly sales:Worldwide sales of $290.4 millionUnited States sales of $210.5 millionWorldwide pump shipments of 38,000United States pump shipments of 27,000Delivered meaningful operational improvement:Record quarterly gross margin of 58%Operating income of $8.3 million, or 3% of salesNet loss of $0.6 million with positive adjusted EBITDA(1) of 11% of salesPositive cash flow from operating activities of $9.8 million and positive free cash flow(1) of $3.1 millionDelivered key portfolio enhancements:Began global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus continuous glucose monitoring
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- Tandem Diabetes Care (NASDAQ:TNDM) was given a new $22.00 price target on by analysts at Mizuho.MarketBeat
- Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "hold" rating on the stock.MarketBeat
- Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $30.00 price target on the stock, up previously from $15.00.MarketBeat
- Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at Piper Sandler.MarketBeat
TNDM
Earnings
- 2/19/26 - Beat
TNDM
Sec Filings
- 2/19/26 - Form 4
- 2/19/26 - Form 4
- 2/19/26 - Form 4
- TNDM's page on the SEC website